Resiglitazone (PENDING)

UNDER REVIEW (April 2017)


Drug specifics

Alternative drug name not specified
Effects not specified
Adverse actions not specified
Dose not specified
Interactions not specified
Contraindications not specified
Comments not specified
Contributors